Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Assertio Holdings regains compliance with Nasdaq minimum bid price rule » 09:37
06/04/21
06/04
09:37
06/04/21
09:37
ASRT

Assertio Holdings

$1.79 /

-0.03 (-1.65%)

Assertio Holdings…

Assertio Holdings announced that that it received a notification letter from the Listing Qualifications Department of The Nasdaq Stock Market indicating that the Company has regained compliance with the minimum bid price requirement set forth in Rule 5550(a)(2) of the Nasdaq Listing Rules Accordingly, the Company has regained compliance with the Minimum Bid Price Requirement and this matter is now closed.

ShowHide Related Items >><<
ASRT Assertio Holdings
$1.79 /

-0.03 (-1.65%)

ASRT Assertio Holdings
$1.79 /

-0.03 (-1.65%)

04/09/21 Gabelli
Assertio Holdings upgraded to Buy from Hold at Gabelli
12/17/20 Gabelli
Assertio Therapeutics downgraded to Hold from Buy at Gabelli
09/18/20 Gabelli
Assertio Therapeutics initiated with a Buy at Gabelli
ASRT Assertio Holdings
$1.79 /

-0.03 (-1.65%)

Hot Stocks
Assertio Holdings announces adjournment of Annual Meeting of Shareholders » 06:36
05/17/21
05/17
06:36
05/17/21
06:36
ASRT

Assertio Holdings

/

+

Assertio Holdings…

Assertio Holdings announced partial results and the partial adjournment of the Company's 2021 Annual Meeting of Shareholders, which was held at 1:00 p.m. Central Time on May 11, 2021 and at which time all director nominees were elected and Proposals 4 and 5, as set forth in the Company's Definitive Proxy Statement, were approved by stockholders. The Company adjourned the meeting with respect to Proposal 2 and Proposal 3 for the limited purpose of allowing additional time for stockholders to vote. Support for Proposal 2 has exceeded 80% of the votes cast on the proposal, though approval of more than 50% of all of the Company's outstanding shares of common stock is necessary for the proposal to be approved. While the votes cast prior to adjournment strongly favor Proposal 2, approximately 86 million shares remained unvoted on the proposal at the time of adjournment. The principal reason for the Reverse Split and Proportional Authorized Shares Reduction Proposal is to give the Board discretion to increase the per-share trading price of the Company's common stock to meet the minimum bid price requirements for continued listing on Nasdaq. Support for Proposal 3 has exceeded 76% of the votes cast on the proposal. However, approval of more than 50% of all of the Company's outstanding shares of common stock is necessary for the proposal to be approved. While the votes cast prior to adjournment strongly favor Proposal 3, approximately 86 million shares remained unvoted at the time of adjournment. Both leading independent proxy advisory firms, Institutional Shareholder Services and Glass Lewis & Co., have recommended in favor of the Reverse Split and Proportional Authorized Shares Reduction Proposal and the Increase in Authorized Shares Proposal.

ShowHide Related Items >><<
ASRT Assertio Holdings
/

+

ASRT Assertio Holdings
/

+

04/09/21 Gabelli
Assertio Holdings upgraded to Buy from Hold at Gabelli
12/17/20 Gabelli
Assertio Therapeutics downgraded to Hold from Buy at Gabelli
09/18/20 Gabelli
Assertio Therapeutics initiated with a Buy at Gabelli
06/02/20 Brookline
Assertio Therapeutics initiated with a Buy at Brookline
ASRT Assertio Holdings
/

+

Hot Stocks
Assertio Holdings announces 1-for-4 stock split » 06:34
05/17/21
05/17
06:34
05/17/21
06:34
ASRT

Assertio Holdings

/

+

Assertio Holdings…

Assertio Holdings announced that it has filed a Certificate of Amendment to its certificate of incorporation to implement a one-to-four reverse split of its issued and outstanding common stock. The Reverse Split will become effective as of 12:01 a.m. Eastern Time on May 18, 2021, and the Company's common stock will begin trading on a split-adjusted basis when the market opens on May 18, 2021.

ShowHide Related Items >><<
ASRT Assertio Holdings
/

+

ASRT Assertio Holdings
/

+

04/09/21 Gabelli
Assertio Holdings upgraded to Buy from Hold at Gabelli
12/17/20 Gabelli
Assertio Therapeutics downgraded to Hold from Buy at Gabelli
09/18/20 Gabelli
Assertio Therapeutics initiated with a Buy at Gabelli
06/02/20 Brookline
Assertio Therapeutics initiated with a Buy at Brookline
ASRT Assertio Holdings
/

+

Over a month ago
Hot Stocks
Assertio Holdings, Cover partner to make CAMBIA, SPRIX available online » 09:07
05/05/21
05/05
09:07
05/05/21
09:07
ASRT

Assertio Holdings

/

+

Assertio Holdings and…

Assertio Holdings and Cove announced a collaboration to make CAMBIA for oral solution and SPRIX nasal spray available to Cove's patient population. Using Cove's online telemedicine platform, patients complete a consultation with a licensed physician who can prescribe a variety of treatment options, including CAMBIA for a patient's acute treatment of migraine attacks with or without aura in adults and SPRIX for short-term management of moderate to moderately severe pain which requires analgesia at the opioid level in adults.

ShowHide Related Items >><<
ASRT Assertio Holdings
/

+

ASRT Assertio Holdings
/

+

04/09/21 Gabelli
Assertio Holdings upgraded to Buy from Hold at Gabelli
12/17/20 Gabelli
Assertio Therapeutics downgraded to Hold from Buy at Gabelli
09/18/20 Gabelli
Assertio Therapeutics initiated with a Buy at Gabelli
06/02/20 Brookline
Assertio Therapeutics initiated with a Buy at Brookline
ASRT Assertio Holdings
/

+

Upgrade
Assertio Holdings upgraded to Buy from Hold at Gabelli » 08:17
04/09/21
04/09
08:17
04/09/21
08:17
ASRT

Assertio Holdings

/

+

Gabelli analyst Kevin…

Gabelli analyst Kevin Kedra upgraded Assertio Holdings to Buy from Hold with a 2021 private market value estimate of 80c. The 38% selloff in shares since last month's Q4 results creates a "more compelling" valuation, Kedra tells investors in a research note. Further, the analyst has increased confidence in Assertio's restructuring efforts and hub-based operating model after recent conversations with management. Kedra feels better about the company's ability to maximize cash flow through the hub-focused business model while limiting revenue disruption from the lack of a field sales force.

ShowHide Related Items >><<
ASRT Assertio Holdings
/

+

ASRT Assertio Holdings
/

+

12/17/20 Gabelli
Assertio Therapeutics downgraded to Hold from Buy at Gabelli
09/18/20 Gabelli
Assertio Therapeutics initiated with a Buy at Gabelli
06/02/20 Brookline
Assertio Therapeutics initiated with a Buy at Brookline
ASRT Assertio Holdings
/

+

Over a quarter ago
Syndicate
Assertio Therapeutics raises $34.3M in a registered direct offering » 06:01
02/10/21
02/10
06:01
02/10/21
06:01
ASRT

Assertio Holdings

$1.18 /

+0.16 (+15.69%)

Assertio Therapeutics…

Assertio Therapeutics announced it has entered into a securities purchase agreement with certain institutional investors to purchase 35,000,000 shares of its common stock at a price of 98c per share, which is a premium to market based on applicable Nasdaq "minimum price" rules. Roth Capital Partners acted as the sole placement agent in connection with the offering.

ShowHide Related Items >><<
ASRT Assertio Holdings
$1.18 /

+0.16 (+15.69%)

ASRT Assertio Holdings
$1.18 /

+0.16 (+15.69%)

12/17/20 Gabelli
Assertio Therapeutics downgraded to Hold from Buy at Gabelli
09/18/20 Gabelli
Assertio Therapeutics initiated with a Buy at Gabelli
06/02/20 Brookline
Assertio Therapeutics initiated with a Buy at Brookline
02/12/20 Piper Sandler
Collegium price target raised to $35 from $27 at Piper Sandler
ASRT Assertio Holdings
$1.18 /

+0.16 (+15.69%)

Options
Unusually active option classes on open February 9th » 09:40
02/09/21
02/09
09:40
02/09/21
09:40
TYME

Tyme Technologies

$2.64 /

+ (+0.00%)

, ASRT

Assertio Holdings

$1.02 /

+ (+0.00%)

, ON

ON Semiconductor

$39.81 /

+0.01 (+0.03%)

, UBS

UBS

$15.34 /

+ (+0.00%)

, GTE

Gran Tierra

$0.75 /

+ (+0.00%)

, CRSR

Corsair Gaming

$45.97 /

+ (+0.00%)

, NRZ

New Residential

$10.11 /

+ (+0.00%)

, BP

BP

$22.03 /

+ (+0.00%)

, XOM

Exxon Mobil

$51.23 /

+0.87 (+1.73%)

, BLNK

Blink Charging

$52.07 /

+ (+0.00%)

Unusual total active…

Unusual total active option classes on open include: Tyme Technologies (TYME), Assertio Therapeutics (ASRT), ON Semiconductor (ON), UBS (UBS), Gran Tierra (GTE), Corsair Gaming (CRSR), New Residential (NRZ), BP (BP), Exxon Mobil (XOM), and Blink Charging (BLNK).

ShowHide Related Items >><<
XOM Exxon Mobil
$51.23 /

+0.87 (+1.73%)

UBS UBS
$15.34 /

+ (+0.00%)

TYME Tyme Technologies
$2.64 /

+ (+0.00%)

ON ON Semiconductor
$39.81 /

+0.01 (+0.03%)

NRZ New Residential
$10.11 /

+ (+0.00%)

GTE Gran Tierra
$0.75 /

+ (+0.00%)

CRSR Corsair Gaming
$45.97 /

+ (+0.00%)

BP BP
$22.03 /

+ (+0.00%)

BLNK Blink Charging
$52.07 /

+ (+0.00%)

ASRT Assertio Holdings
$1.02 /

+ (+0.00%)

TYME Tyme Technologies
$2.64 /

+ (+0.00%)

ASRT Assertio Holdings
$1.02 /

+ (+0.00%)

12/17/20 Gabelli
Assertio Therapeutics downgraded to Hold from Buy at Gabelli
09/18/20 Gabelli
Assertio Therapeutics initiated with a Buy at Gabelli
06/02/20 Brookline
Assertio Therapeutics initiated with a Buy at Brookline
02/12/20 Piper Sandler
Collegium price target raised to $35 from $27 at Piper Sandler
ON ON Semiconductor
$39.81 /

+0.01 (+0.03%)

02/02/21 JPMorgan
ON Semiconductor price target raised to $37.50 from $25.50 at JPMorgan
02/02/21 Needham
ON Semiconductor price target raised to $45 from $38 at Needham
02/02/21 Craig-Hallum
ON Semiconductor price target raised to $43 from $38 at Craig-Hallum
02/02/21 Benchmark
ON Semiconductor price target raised to $45 from $36 at Benchmark
UBS UBS
$15.34 /

+ (+0.00%)

01/27/21 Barclays
UBS price target raised to CHF 13.40 from CHF 12 at Barclays
01/27/21 Morgan Stanley
UBS price target raised to CHF 15 from CHF 14 at Morgan Stanley
01/27/21 JPMorgan
UBS price target raised to CHF 16 from CHF 15 at JPMorgan
01/27/21 Deutsche Bank
UBS price target raised to CHF 13 from CHF 12 at Deutsche Bank
GTE Gran Tierra
$0.75 /

+ (+0.00%)

01/14/21 Scotiabank
Gran Tierra price target raised to C$0.65 from C$0.55 at Scotiabank
10/16/20 National Bank
Gran Tierra price target lowered to C$0.40 from C$0.50 at National Bank
08/06/20 Peel Hunt
Gran Tierra upgraded to Buy from Hold at Peel Hunt
06/03/20 BMO Capital
Gran Tierra downgraded to Market Perform from Outperform at BMO Capital
CRSR Corsair Gaming
$45.97 /

+ (+0.00%)

01/26/21 Baird
Corsair Gaming price target raised to $44 from $41 at Baird
12/15/20 Macquarie
Corsair Gaming price target raised to $42 from $30 at Macquarie
12/02/20 Cowen
Corsair Gaming downgraded to Market Perform at Cowen on valuation
12/02/20 Cowen
Corsair Gaming downgraded to Market Perform from Outperform at Cowen
NRZ New Residential
$10.11 /

+ (+0.00%)

12/18/20 Keefe Bruyette
New Residential upgraded to Outperform from Market Perform at Keefe Bruyette
12/14/20 Jefferies
New Residential initiated with a Buy at Jefferies
11/24/20 B. Riley
New Residential price target raised to $11.50 from $9.50 at B. Riley Securities
11/23/20 BTIG
New Residential assumed with a Buy at BTIG
BP BP
$22.03 /

+ (+0.00%)

02/03/21 RBC Capital
BP price target lowered to 280 GBp from 310 GBp at RBC Capital
02/03/21 Credit Suisse
BP price target lowered to 350 GBp from 380 GBp at Credit Suisse
01/26/21 MKM Partners
BP initiated with a Buy at MKM Partners
01/21/21 Jefferies
BP initiated with a Hold at Jefferies
XOM Exxon Mobil
$51.23 /

+0.87 (+1.73%)

02/08/21
Fly Intel: Top five analyst upgrades
02/08/21 Exane BNP Paribas
Exxon Mobil upgraded to Neutral from Underperform at Exane BNP Paribas
02/08/21 Exane BNP Paribas
Exxon Mobil upgraded to Neutral from Underperform at Exane BNP Paribas
01/21/21 Jefferies
Exxon Mobil initiated with an Underperform at Jefferies
BLNK Blink Charging
$52.07 /

+ (+0.00%)

02/05/21 Roth Capital
Blink Charging initiated with a Buy at Roth Capital
08/14/20
Fly Intel: Top five analyst downgrades
08/14/20 H.C. Wainwright
Blink Charging downgraded to Neutral from Buy at H.C. Wainwright
XOM Exxon Mobil
$51.23 /

+0.87 (+1.73%)

UBS UBS
$15.34 /

+ (+0.00%)

ON ON Semiconductor
$39.81 /

+0.01 (+0.03%)

NRZ New Residential
$10.11 /

+ (+0.00%)

CRSR Corsair Gaming
$45.97 /

+ (+0.00%)

BP BP
$22.03 /

+ (+0.00%)

BLNK Blink Charging
$52.07 /

+ (+0.00%)

  • 22
    Jan
  • 08
    Jan
  • 23
    Sep
XOM Exxon Mobil
$51.23 /

+0.87 (+1.73%)

UBS UBS
$15.34 /

+ (+0.00%)

ON ON Semiconductor
$39.81 /

+0.01 (+0.03%)

GTE Gran Tierra
$0.75 /

+ (+0.00%)

BP BP
$22.03 /

+ (+0.00%)

BLNK Blink Charging
$52.07 /

+ (+0.00%)

XOM Exxon Mobil
$51.23 /

+0.87 (+1.73%)

UBS UBS
$15.34 /

+ (+0.00%)

TYME Tyme Technologies
$2.64 /

+ (+0.00%)

ON ON Semiconductor
$39.81 /

+0.01 (+0.03%)

NRZ New Residential
$10.11 /

+ (+0.00%)

CRSR Corsair Gaming
$45.97 /

+ (+0.00%)

BLNK Blink Charging
$52.07 /

+ (+0.00%)

XOM Exxon Mobil
$51.23 /

+0.87 (+1.73%)

UBS UBS
$15.34 /

+ (+0.00%)

TYME Tyme Technologies
$2.64 /

+ (+0.00%)

ON ON Semiconductor
$39.81 /

+0.01 (+0.03%)

NRZ New Residential
$10.11 /

+ (+0.00%)

GTE Gran Tierra
$0.75 /

+ (+0.00%)

CRSR Corsair Gaming
$45.97 /

+ (+0.00%)

BP BP
$22.03 /

+ (+0.00%)

BLNK Blink Charging
$52.07 /

+ (+0.00%)

Syndicate
Assertio Therapeutics prices 22.6M share registered direct offering at 62c/shr » 06:11
02/05/21
02/05
06:11
02/05/21
06:11
ASRT

Assertio Holdings

$0.78 /

+0.0831 (+11.95%)

Roth Capital Partners…

Roth Capital Partners acted as the sole placement agent in connection with the offering.

ShowHide Related Items >><<
ASRT Assertio Holdings
$0.78 /

+0.0831 (+11.95%)

ASRT Assertio Holdings
$0.78 /

+0.0831 (+11.95%)

12/17/20 Gabelli
Assertio Therapeutics downgraded to Hold from Buy at Gabelli
09/18/20 Gabelli
Assertio Therapeutics initiated with a Buy at Gabelli
06/02/20 Brookline
Assertio Therapeutics initiated with a Buy at Brookline
02/12/20 Piper Sandler
Collegium price target raised to $35 from $27 at Piper Sandler
Hot Stocks
Assertio Therapeutics announces $5M insurance settlement » 16:42
02/03/21
02/03
16:42
02/03/21
16:42
ASRT

Assertio Holdings

$0.70 /

+0.0001 (+0.01%)

Assertio Therapeutics has…

Assertio Therapeutics has entered into a confidential settlement agreement and mutual release with its primary product liability insurer, Navigators Specialty Insurance Company and Navigators Insurance Company. The settlement agreement resolves the previously disclosed declaratory judgment action that Navigators filed in 2019, and Assertio Therapeutics' related counterclaims, stemming from a dispute as to whether the opioid lawsuits brought against Assertio Therapeutics beginning in May 2018 are covered under its life sciences liability policies with Navigators. Pursuant to the settlement agreement, Navigators has agreed to pay $5M of its $10M primary policy to Assertio Therapeutics by February 17. The company is updating its previously stated range for the cost of the restructuring announced on December 15, 2020 from $8M to $10M to $11M-$12M to account for additional non-cash charges relating to the write-off of certain office lease and furniture assets. In addition, the company has determined certain events existed at the end of fiscal year 2020 representing a triggering event for an impairment assessment of its long-lived assets and goodwill. Although the company has not yet completed its impairment assessment, it expects to recognize a non-cash impairment charge of no less than $9M for the quarterly period ended December 31, 2020.

ShowHide Related Items >><<
ASRT Assertio Holdings
$0.70 /

+0.0001 (+0.01%)

ASRT Assertio Holdings
$0.70 /

+0.0001 (+0.01%)

12/17/20 Gabelli
Assertio Therapeutics downgraded to Hold from Buy at Gabelli
09/18/20 Gabelli
Assertio Therapeutics initiated with a Buy at Gabelli
06/02/20 Brookline
Assertio Therapeutics initiated with a Buy at Brookline
02/12/20 Piper Sandler
Collegium price target raised to $35 from $27 at Piper Sandler
Syndicate
Assertio Therapeutics files $100M mixed securities shelf  06:36
01/25/21
01/25
06:36
01/25/21
06:36
ASRT

Assertio Holdings

$0.71 /

-0.061 (-7.87%)

 
ShowHide Related Items >><<
ASRT Assertio Holdings
$0.71 /

-0.061 (-7.87%)

ASRT Assertio Holdings
$0.71 /

-0.061 (-7.87%)

12/17/20 Gabelli
Assertio Therapeutics downgraded to Hold from Buy at Gabelli
09/18/20 Gabelli
Assertio Therapeutics initiated with a Buy at Gabelli
06/02/20 Brookline
Assertio Therapeutics initiated with a Buy at Brookline
02/12/20 Piper Sandler
Collegium price target raised to $35 from $27 at Piper Sandler

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.